<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Goyal N</submitter><funding>NIMHD NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>18</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8555909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7</volume><pubmed_abstract>&lt;h4>Aim&lt;/h4>In this study, our goal was to study the inhibition of nicotine metabolism by P450 2A6, as a means for reduction in tobacco use and consequently the prevention of smoking-related cancers. Nicotine, a phytochemical, is an addictive stimulant, responsible for the tobacco-dependence in smokers. Many of the other phytochemicals in tobacco, including polycyclic aromatic hydrocarbons, N-nitrosamines, and aromatic amines, are potent systemic carcinogens. Tobacco smoking causes about one of every five deaths in the United States annually. Nicotine plasma concentration is maintained by the smokers' smoking behavior within a small range. Nicotine is metabolized by cytochrome P450s 2A6 and 2A13 to cotinine. This metabolism causes a decrease in nicotine plasma levels, which in turn leads t</pubmed_abstract><journal>Journal of cancer metastasis and treatment</journal><pubmed_title>Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine.</pubmed_title><pmcid>PMC8555909</pmcid><funding_grant_id>G12 MD007595</funding_grant_id><funding_grant_id>RL5 GM118966</funding_grant_id><pubmed_authors>Goyal N</pubmed_authors><pubmed_authors>Bratton M</pubmed_authors><pubmed_authors>Foroozesh M</pubmed_authors><pubmed_authors>Shaik S</pubmed_authors><pubmed_authors>Jiang Q</pubmed_authors><pubmed_authors>Sridhar J</pubmed_authors><pubmed_authors>Do C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine.</name><description>&lt;h4>Aim&lt;/h4>In this study, our goal was to study the inhibition of nicotine metabolism by P450 2A6, as a means for reduction in tobacco use and consequently the prevention of smoking-related cancers. Nicotine, a phytochemical, is an addictive stimulant, responsible for the tobacco-dependence in smokers. Many of the other phytochemicals in tobacco, including polycyclic aromatic hydrocarbons, N-nitrosamines, and aromatic amines, are potent systemic carcinogens. Tobacco smoking causes about one of every five deaths in the United States annually. Nicotine plasma concentration is maintained by the smokers' smoking behavior within a small range. Nicotine is metabolized by cytochrome P450s 2A6 and 2A13 to cotinine. This metabolism causes a decrease in nicotine plasma levels, which in turn leads t</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-05-29T19:01:09.321Z</modification><creation>2022-02-11T12:27:47.435Z</creation></dates><accession>S-EPMC8555909</accession><cross_references><pubmed>34722929</pubmed><doi>10.20517/2394-4722.2020.143</doi></cross_references></HashMap>